• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.

作者信息

Abruzzese Elisabetta, Trawinska Malgorzata Monika, Neri Benedetta, Bondanini Francesco, Fratoni Stefano, Tendas Andrea, Scaramucci Laura, Siniscalchi Agostina, Giovannini Marco, Palumbo Roberto, de Fabritiis Paolo, Niscola Pasquale

机构信息

Hematology Unit, S. Eugenio Hospital (ASL Roma 2), Rome, Italy.

UOC of Clinical Pathology, S. Eugenio Hospital (ASL Roma 2), Rome, Italy.

出版信息

Acta Haematol. 2018;140(4):231-233. doi: 10.1159/000493880. Epub 2018 Nov 1.

DOI:10.1159/000493880
PMID:30384359
Abstract
摘要

相似文献

1
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.地西他滨成功治疗不适合化疗的慢性骨髓增殖性肿瘤后急性髓系白血病老年患者
Acta Haematol. 2018;140(4):231-233. doi: 10.1159/000493880. Epub 2018 Nov 1.
2
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.地西他滨治疗原发性血小板增多症转化后多发髓外急性髓系白血病累及情况
Acta Oncol. 2017 Oct;56(10):1331-1333. doi: 10.1080/0284186X.2017.1324215. Epub 2017 May 10.
3
Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: Biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor.真性红细胞增多症继发的急性髓系白血病在化疗后逆转至骨髓增殖性肿瘤慢性期：具有共同早期造血祖细胞基因组证据的双克隆性骨髓肿瘤
Hematol Oncol. 2021 Apr;39(2):254-257. doi: 10.1002/hon.2824. Epub 2020 Nov 10.
4
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms.达珂®联合维奈托克®治疗骨髓增生性肿瘤相关的急性髓系白血病。
Future Oncol. 2023 Jan;19(2):103-111. doi: 10.2217/fon-2022-0512. Epub 2023 Jan 18.
5
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.骨髓增殖性肿瘤白血病转化的基因组和功能分析
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10. doi: 10.1073/pnas.1407792111. Epub 2014 Dec 2.
6
A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia.鲁索替尼与地西他滨治疗骨髓增殖性肿瘤后急性髓系白血病患者的1/2期研究。
Leukemia. 2020 Sep;34(9):2489-2492. doi: 10.1038/s41375-020-0778-0. Epub 2020 Feb 25.
7
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.骨髓增殖性肿瘤和急性髓系白血病中JAK2 46/1单倍型分析
Leukemia. 2010 Oct;24(10):1809-13. doi: 10.1038/leu.2010.172. Epub 2010 Sep 2.
8
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.骨髓增殖性肿瘤慢性期低负担 TP53 突变：与年龄、羟基脲治疗、疾病类型和 JAK2 突变状态的关联。
Leukemia. 2018 Feb;32(2):450-461. doi: 10.1038/leu.2017.230. Epub 2017 Jul 24.
9
Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.骨髓增殖性肿瘤后急性髓系白血病中TET2突变的分析
Leukemia. 2010 Jan;24(1):201-3. doi: 10.1038/leu.2009.169. Epub 2009 Aug 27.
10
[Application of novel tyrosine-kinase inhibitors for the treatment of leukemia and Ph-negative myeloproliferative neoplasms].新型酪氨酸激酶抑制剂在白血病和Ph阴性骨髓增殖性肿瘤治疗中的应用
Rinsho Ketsueki. 2011 Jul;52(7):460-8.

引用本文的文献

1
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation.通过挽救性地西他滨桥接异基因移植治疗阿扎胞苷治疗失败的骨髓增生异常综合征后难治性急性髓系白血病的长期反应
Blood Res. 2019 Dec;54(4):288-290. doi: 10.5045/br.2019.54.4.288. Epub 2019 Dec 20.